Trials / Completed
CompletedNCT00914680
Berlin Magnetic Seizure Therapy Depression Trial 01
Investigation of Efficacy and Tolerability of Magnetic Seizure Therapy in the Treatment of Depression
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 25 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This treatment pilot study will investigate clinical efficacy and adverse effects of magnetic seizure therapy (MST) in patients currently experiencing a unipolar or bipolar depressive episode. The investigators will perform add-on tests to assess clinical and cognitive response to treatment. It is hypothesized that MST will have an antidepressant efficacy with a beneficial neurocognitive adverse effect profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | magnetic seizure therapy | antidepressant treatment with MST |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2012-05-01
- Completion
- 2013-05-01
- First posted
- 2009-06-05
- Last updated
- 2018-07-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00914680. Inclusion in this directory is not an endorsement.